Professional Documents
Culture Documents
Page 1/7
Review
A R T I C L E I N F O A B S T R A C T
Article history French health insurance databases are organized smce 2003 into a huge digital data warehouse, the
Available online 26 December 2014 Systme national d'information mter-rgime de /'assurance maladie (SNIIR-AM) It covers the entire French
population (65 million mhabitants). In order to facilitate studies on more frquent conditions, a random
Keywords sample of I /97th of national health system beneficianes has been built smce 2005, called the chantillon
Health Insurance gnraliste des bnficiaires (EGB). The aim of this article is to descnbe the main charactenstics of the
Mdico-administrative databases SNIIR-AM and the EGB, to dtail their accessibilite accordmg to French law, and to present their strengths
France
and lumts. It is illustrated with the most rcent studies conducted in these databases. These databases
Systeme national d'information mter-regime
de l'assurance maladie
include dmographie, out-hospital reimbursement (includmg drug dispensmg), medical (costly long-
chantillon gnraliste des bnficiaires term diseases, occupational diseases, sick-leaves ), and m-hospital data All these data are prospective^
recorded, individualized, made anonymous and hnkable Consequently, the SNIIR-AM is a very useful data
source for epidemiology!, pharmacoepidemiological and health economies studies, particularly for rare
diseases. The EGB is appropnate for long-term research on more frquent diseases.
O 2014 Socit nationale franaise de mdecine interne (SNFMI). Published by Elsevier Masson SAS.
All nghts reserved.
R E S U M E
Mots cles Les bases de donnes de l'assurance maladie sont collectes depuis 2003 dans un vaste entrept
Assurance maladie numrique, le Systme national d'information mter-rgime de l'assurance maladie (SNIIR-AM). La rsul-
Base de donnes mdico-administrative tante en est une des plus grandes bases mdico-administratives au monde, couvrant 65 millions de
France personnes Afin de faciliter l'tude de cohortes de patients atteints de maladies plus frquentes, un
Systeme national d'information chantillon au I /97e des assurs l'assurance maladie a t constitu depuis 2005 l'chantillon gnral-
mter-rgime de l'assurance maladie
iste des bnficiaires (EGB). L'objectif de cette mise au point est de prsenter les grandes lignes de
chantillon gnraliste des bnficiaires
l'architecture du SNIIR-AM et de l'EGB, leurs modalits d'accs, leurs intrts et leurs limites. Leur
potentiel en recherche mdicale est illustr par les publications les plus rcentes. Ces bases de donnes
contiennent des donnes dmographiques, les donnes de remboursements des prestations ambulatoires
(dont les dlivrances de mdicaments), les donnes mdicales des rgimes de l'assurance maladie (affec-
tions de longue dure, maladies professionnelles, arrts de travail ) et les donnes hospitalires issues
du programme de mdicalisation des systmes d'information. Toutes ces donnes sont individuelles,
* The French version of this article is available online (see Appendix A at the end of the text)
* Corresponding author
E-mail address guillaume moulis@univ-tlse3 fr (G Moulis)
Page 2/7
prospectivement recueillies, anonymises et chanables Tout cela fait du SNIIR-AM une source de donnes
trs intressante pour la recherche pidmiologique, pharmacopidmiologique et en conomie de la
sant, particulirement pour les maladies rares L'EGB est particulirement utile l'tude des maladies
plus frquentes et sur le long terme
2014 Socit nationale franaise de mdecine interne (SNFMI). Publi par Elsevier Masson SAS Tous
droits rserves
As in North American and other European countnes. French hospitals fi om 2007 to 2010, and by linkage with dates of death
public authonties want to develop the use of national mdico- (smce2009) [I].
administrative databases for research. For that purpose, their Its general architecture and main recorded data are descnbed in
accessibihty to researchers is regularly improved [1-3]. This arti- Fig I.
cle is focused on the use of the French national health insurance The inter-scheme consumption data (donnes de consomma-
system databases for medical research. tion mter-rgimes [DCIR]) set includes all outpatient reimbursed
The French universal health insurance system manages, through health expenditures. These data are transmitted in real time by the
public antilles, all reimbursements of healthcare to all people CNAMTS and the various special insurance schemes.
affihated to a health insurance scheme in France Accounts manage- This DCIR database is also linked with data from the health insur-
ment requires the generation of centralized databases, containing ance medical service that includes information about long-term
also administrative data. The resuit is one of the largest global diseases [LTD), occupational accidents, and occupational diseases.
database of medical and administrative data in the general pop- PMSI data stern from all private or public hospitals and are pro-
ulation, covenng nearly 65 million persons, fai ahead of the vided to the CNAMTS for linkage to the SNIIR-AM. Information
UK's Clmical Practice Research Datalmk (approximately five mil- includes the hospital identifier, the dates of start and end of stays,
lion persons), the Quebec Health Insurance Corporation (Rgie de the diagnostic codes (one primary diagnosis, one related diagno-
l'assurance maladie du Qubec, approximately four million per- sis and up to 30 associated diagnoses coded with the International
sons) oi these of northern European countnes [I ]. Healthcare data Classification of Diseases, version ICD-10 [8]), the diagnosis-related
are collected prospective^ at the local level, and then transmit- group (groupe homogne de malades [GHM]) codmg, the proce-
ted to the National Health Insurance Fund for Salaned Workers dures (Classification commune des actes mdicaux [CCAMJ codmg),
(Caisse nationale de l'assurance maladie des travailleurs salaris the costly drugs dispensed, whether the stays occurred in a special
[CNAMTS]) that hosts all the data in a huge digital warehouse unit (resuscitation, intensive care, neonatology or palliative care),
called the National Health Insurance Inter-Scheme Information and a score of seventy for stays in intensive care umts (Simphfied
System (Systme national d'information mter-rgime de l'assurance Acute Physiology Score ll). A database exists for Mdiane, Surgery
maladie [SNIIR-AM]) [1,4]. All SNIIR-AM data are hnkable: it is and Obstetncs hospitalisations (PMSI MCG for mdecine chirurgie
possible to identify and to link all data corresponding to a given obsttrique), one for psychiatry (PMSI PSY for psychiatrie), one for
beneficiary among the dozen of tables contamed in the SNIIR- home hospitalisations (PMSI HAD for hospitalisaiton domicile), and
AM. one for after-care and rehabilitation (PMSI SSR for soins de suite et
Due to its width and to the individual, prospective and com- de radaptation) PMSI data are updated every three months [1,4].
plte data recording for all beneficianes, the SNIIR-AM is a very Demographics (age, gender, place of residence -mumcipality
useful data source for medical research in the field of epidemiol- code, advantage of the Universal Health Coverage, affihate scheme)
ogy, pharmacoepidermology and health economies of rare diseases. are available in the DCIR and PMSI databases.
To facihtate the building of patient cohorts for the most common Data of a given individual are hnked through a unique identifi-
diseases, a sample of l/97th of the SNIIR-AM bas been established cation number named numro d'identification au rpertoire (NIR),
smce 2005 in order to provide a 20-year follow-up of beneficianes which is a unique identifier for each insured person. However,
This sample is named the permanent beneficianes sample (chan- the NIR is not accessible in the SNIIR-AM in order to prserve the
tillon gnraliste de bnficiaires [EGB]) [4,5]. identity of patients. It is made anonymous by a complex two level
The ann of this article is to descnbe the main charactenstics procedure called/cmcfion d'occultation des informations nominatives
of the SNIIR-AM and the EGB aichitectuies, to piesent the condi- (FOIN), winch is completely irrversible This makes it difficult to
tions for accessing to them and their main strengths and limitations match climcal cohort data with SNIIR-AM data (Sec Section 2) [I].
when used for medical research. The potential of these databases The depth of the SNIIR-AM is three years plus the current year.
in medical research is illustrated by the most rcent publications. PMSI data kept by the Technical Agency for Hospitalisation Infor-
mation (Agence technique d'information sur l'hospitalisation [ATIH])
have a shding depth of IO years plus the current year. The law allows
I. Simplifie! architecture of the SNIIR-AM and the EGB conservation of successive SNIIR-AM extractions corresponding to
lOyears of follow-up [7].
1.1 The SNIIR-AM
The SNIIR-AM was created in 2003 following the 1999 social 12. The ECS
secunty fundmg law [6]. Its objectives are to improve the qual-
ity of healthcare, contribute to a hetier management of the Heallh The EGB lias been established in 2005. It is a sample of l/97th
Insurance Syslem and of public heallh polices, and inform heallh of insured persons in France, corresponding to 660,000 persons
praclilioners as regards Iheir activity, accounts and prescnplions [4,5]. Il is built by a random selection of NIRs repiesentative of
[7]. Initially consistmg of only CNAMTS dala (86% of insured the French population by gender and by five-year incrments [4]
palienls), il was gradually ennched in 2009 by lhc dala of all The population of the EGB includes insured persons, whether they
insured patients by linkage with information of the programme for are receivmg healthcare or not In contrast, only individual receiv-
the medicalization of information systems (programme de mdi- ing healthcare are present in the SNIIR-AM. All health insuiance
calisation des systmes d'information [PMSI]) of public and private schemes are included, except some special insurance schemes,
Tous droits rservs l'diteur SANTE2 6564384400503
Date : JUIN 15
Page de l'article : p.51-57
Journaliste : G. Moulis / M.
Pays : France Lapeyre-Mestre / A. Palmaro /
Priodicit : Mensuel G. Pugnet / J.-L Montastruc /
L. Sailler
Page 3/7
e l'Informmmn
\ i l'Hospitalisatia
Medical data Dmographie data PMSI MCG, PSY, SSR, HAD Date of death
Costly long term diseases Age, gender, place of Entry and release dates
Occupational accidents residency insurance scheme Principal, related and associated diagnoses
Occupational diseases benefrtfrom the Universal Procedures
Sick leaves Health Coverage Costly drugs
Special unit intensive care palliative care
Out-hospital reimbursements
Date person who prescribes and who dispenses the care
For drugs name, form, quantity dispensed
whose data are progressively implemented Data available are Direct access to the SNIIR-AM is not possible Followmg autho-
these of the SNIIR-AM They are also anonymous Individual data nzation from the IDS and the National Data Protection Commission
are stored and accessible for 20 years When a patient dies emi- (Commission nationale de l'informatique et des liberts [CNIL]),
grates or is no longer msured, ne or she is considered out of the CNAMTS engineers extract from the SNIR-AM the study popula-
cohort his/her data are retamed but censored on the release date tion accordmg to the inclusion and non-inclusion cnteria given to
Newly msured pei sons are added quarterly to the EGB to keep con- them Data are supplied on a secure, electronic mdium
stant the proportion of l/97th of the msured persons in France As noted above, SNIIR-AM and EGB data are irreversibly anony-
[4] mous Collecting the patients' NIR in a chnical cohort (in order to
Table I compares the SNIIR-AM with EGB Because of the depth link cohort data with SNIIR-AM data) currently requires a State
of the database and accessibihty, the EGB is a database of choice for Council (Conseil d'Etat) decree, making this an almost impossible
long-term cohorts of patients with common diseases strategy in practice A second strategy is to identify the NIRs achiev-
ing a probabihstic matching It consists in recording in the chnical
2. Conditions for accessing the SNIIR-AM and the ECB cohort indirect identifymg data (date and place of birth, gender),
plus possibly directly identifymg data (name and surname) Then,
Conditions for accessing the SNIIR-AM and the EGB are stnctly these data are seai cheri in the NIR i epertory in ot dei to ti y to iden-
regulated by law [7] The Health Data Institute (Institut des donnees tify the NIR that corresponds to a given patient However this later
de sante [IDS]) ensures the consistency of mdico-administrative strategy can lead to errors and non-completeness in NIR identifi
databases, data quality and availabihty of databases for research cation [I]
[9] Any access request to the SNIIR-AM or the EGB for a pioject
requires automation from the IDS Only non-profit research can
apply[10] 3. Advantages and limitations
Access to the EGB requires a direct secured connection to a
devoted server, with no possibihty to import data As there is no The advantages and limitations of the SNIIR-AM and of the
database creation, only authonzation from the IDS is required EGB with existmg or planned solutions to the limitations are
Tous droits rservs l'diteur SANTE2 6564384400503
Date : JUIN 15
Page de l'article : p.51-57
Journaliste : G. Moulis / M.
Pays : France Lapeyre-Mestre / A. Palmaro /
Priodicit : Mensuel G. Pugnet / J.-L Montastruc /
L. Sailler
Page 4/7
Table I
Companson of the Systeme national d information inter regime de I assurance maladie (SMUR AM) to the chantillon gnraliste des bnficiaires (EGB)
SNIIR AM ECB
Population All insurance schemes (smce 2009) Dynamic sample of I /97th ( n = 660 DOO) of msured persons in France
Only individual receivmg reimbursed healthcare (patients) except SI M and some rare insurance schemes (not necessanly ill)
Benefiting trom health care or not
Rareproblemoflossoffollow up
Database depth 3 yeais + thecurrentyear lOyears fat the PMSI Recording durmg 20 years (start in 2005)
Possibihty to stock data (bf IQ years
Data Out-hospital reimbursed healthcare Out hospital reimbursed health cares
ALD work accidents occupational diseases sick leaves ALD work accidents occupational diseases sick leaves
PMSI MCG PSY HAD SSR PMSI MCG only
Access Non profit research organization Non profit research organization
1DS authonzation IDS authorization
CNIL authorization Direct access by connection to ECB server
Extraction by CNAMTS engineers
Preferential use Studies on rare diseases Diseases with high prevalence
Studies needing rapid results
ALD affection de longue duree (long term disease) CNAMTS Caisse nationale de lassurance maladie des travailleurs salaries (National Health Insurance Fund for Salaned
Workers) CNIL Commission nationale de I informatique et des liberts (National Data Protection Commission) EGB chantillon gnraliste des bnficiaires (permanent
beneficianes sample) HAD hospitalisation a domicile (home hospitalization) IDS mstitutdesdonneesdesanre(HealthDatalnstitute) PMSI programme de mdicalisation des
systemes d information (Program for the Medicahzation of Information Systems) PSY psychiatry SLM sections locales mutualistes SMUR AM Systeme national d m/ormation
inter regime de I assurance maladie SSR soins de suite et de readaptation (after care and rehabilitation)
summanzed in Table 2 The main uses of these databases for med millions of hnes A SNIIR AM dictionary is available for users of
ical research are hsted in Table 3 the health insurance databases As the EGB is dedicated to medi-
The mam limitation of these databases is their complexity cal research, a 'simplified EGB' emerged in late 2013, simplifymg
An extraction of the SNIIR-AM bas several dozen of tables, some the presentation of outpatient healthcares However, training on
only used for accountancy, containmg hundreds of variables and the complex architecture of these bases is mandatory smce 2013
Table 2
Advantages and limitations of the SNIIR AM and the EGB
Page 5/7
Page 6/7
Page 7/7
[19] Fagot J-P Boutrelle A, Ricordeau P, Weill A, Allemand H HPV vaccination in new users a cohort study in the French national health insurance database
France uptake costs and issues for the National Health Insurance Vaccine Pharmacoepidemiol Drug Saf 2014,23 240-50
2011,29 3610-6 [28] Weill A, Paita M, Tuppin P, Fagot J-P, Neumann A, Simon D, et al Benfluorex
[20] Moulis G Lapeyre-Mestre M, Adoue D, Sailler L Lexposition aux vaccins and valvular heart disease a cohort study of a million people with diabetes
recommandes est faible chez les patients non splnectomises atteints de melhtus Pharmacoepidemiol Drug Saf 2010 19 1256-62
thrombopnie immunologique primaire et exposs au ntuximab Resultats de [29] Neumann A Weill A, Ricordeau P, Fagot JP Alla F, Allemand H Pioglitazone and
l'tude FA1TH (French Adult Immune Thrombocytopema a pharmacoepidemi- risk of bladder cancer among diabete patients in France a population-based
ological study) Rev Med Interne 2014,35 A78-9 cohort study Diabetologia2012,55 1953-62
[21] Haute Autorite de sant Purpura thrombopemque immunologique de [30] Blin P, Lassalle R, Dureau-Pournm C Ambrosmo B Bernard MA Abouelfath A,
l'enfant et de l'adulte Protocole national de diagnostic et de soins, 2009 et al Insuhn glargme and risk of cancer a cohort study in the French National
http //www has-sante fr/portail/upload/docs/application/pdf/2009-12/ald 2 Healthcare Insurance Database Diabetologia 2012,55 644-53
pnds_pti imune cnft adulte.web pdf [Accessed OI July 2014] [31] Blotiere P-0 Weill A Ricordeau P, Alla F, Allemand H Perforations and
[22] Fautrel B Joubert J-M, Cukierman G, Laurendeau C Gourmelen J Fagnani haemorrhages after colonoscopy in 2010 a study based on comprehen-
F Rheumatoid atlantis (RA) comorbidities and biological agents uptake in sive French health insurance data (SNI1RAM) Clin Res Hepatol Gastroenterol
France analysis of a national claims database Ann Rheum Dis 2013,72 2014,38 112-7
337 [32] Dixon WC Abrahamowicz M, Beauchamp M-E, Ray DW, Bernatsky S, Suissa
[23] Bezm J Panente A, Lassalle R, Dureau-Pournm C, Abouelfath A, Robinson P, et al S, et al Immdiate and delayed impact of oral glucocorticoid therapy on risk
Use of the recommended drug combmation for secondary prevention after a of senous infection in older patients with rheumatoid arthntis a nested case-
first occurrence of acute coronary syndrome in France Eur J Clin Pharmacol control analyse Ann Rheum Dis 2012,71 1128-33
2014,70 429-36 [33] Dixon WC Kezouh A Bernatsky S, Suissa S The influence of systemic glu-
[24] Dupouy J Fournier J-P Jouanjus , Palmaro A Poutram J-C Oustric S cocorticoid therapy upon the risk of non-senous infection in older patients
et al Baclofen for alcohol dependence in France incidence of treated with rheumatoid arthntis a nested case-control study Ann Rheum Dis
patients and prescription patterns a cohort study Eur Neuropsychopharmacol 2011 70 956-60
2014,24 192-9 [34] Moulis G, Sailler L, Adoue D, Lapeyre-Mestre M Pharmacoepidemiology of
[25] Gallmi A, Andneu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette immune thrombocytopema protocols of FAITH and CARMEN studies Therapie
V Trends in use of antipsychotics in elderly patients with dementia 2014,69 437-48
impact of national safety warnings Eur Neuropsychopharmacol 2014,24 [35] World Health Organization ATC/DDD Index, 2014 [Accessed OI July 2014]
95-104 http //www whocc no/atc dddjndex/
[26] Panente A, Pmet M, Monde Y, Merlire Y Moore N, Fourner-Rglat A Fac- [36] Pottegrd A, Hallas J Assigning exposure duration to single prescriptions by
tors associated with persistence of cholmesterase mhibitor treatments in the use of the waiting time distribution Pharmacoepidemiol Drug Saf 2013,22
elderly Pharmacoepidemiol Drug Saf 2010,19 680-6 803-9
[27] Neumann A, Maura G Weill A, Ricordeau P Alla F, Allemand H Comparative [37) Sylvestre M-P, Abrahamowicz M Flexible modehng of the cumulative
effectiveness of rosuvastatin versus simvastatm in pnmary prevention among effects of time-dependent exposures on the hazard Stat Med 2009,28
3437-53